PD Dr. Jan Dörrie



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Individualized neoantigen peptide immunization of a metastatic pancreatic cancer patient: a case report of combined tumor and liquid biopsy (2024) Roehnisch T, Martos-Contreras MC, Manoochehri M, Nogueira M, Bremm F, Dörrie J, Christoph J, et al. Journal article XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors (2023) Heger L, Hatscher L, Liang C, Lehmann C, Amon L, Lühr JJ, Kaszubowski T, et al. Journal article CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy (2023) Harrer DC, Dörrie J, Schaft N Journal article, Review article The future of affordable cancer immunotherapy (2023) Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, et al. Journal article, Review article Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality. (2023) Pfister F, Dörrie J, Schaft N, Buchele V, Unterweger H, Carnell LR, Schreier P, et al. Journal article Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML (2022) Fujii SI, Kawamata T, Shimizu K, Nakabayashi J, Yamasaki S, Iyoda T, Shinga J, et al. Journal article Guidelines for mouse and human DC generation (2022) Lutz MB, Ali S, Audiger C, Autenrieth SE, Berod L, Bigley V, Cyran L, et al. Journal article Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells (2022) Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N Journal article Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases (2022) Beenen AC, Sauerer T, Schaft N, Dörrie J Journal article, Review article A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) Koch E, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, Dörrie J, Schuler-Thurner B Journal article